Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Income
—
Filings
101
Unique Clients
1
Active Period
2000–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
PREVENT HPV Cancers Act of 2023
2024 · fourth_quarter · Client: BECTON DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023 H.R.4261, ARC Act of 2023
Client expense: $485,000 · Firm income: —
Matched citations: H.R.3633
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023 H.R.4261, ARC Act of 2023
Client expense: $485,000 · Firm income: —
Matched citations: H.R.4261
PREVENT HPV Cancers Act of 2023
2024 · third_quarter · Client: BECTON DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023
Client expense: $400,000 · Firm income: —
Matched citations: H.R.3633
VALID Act of 2023
2024 · second_quarter · Client: BECTON DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute H.R.2369,VALID Act of 2023 U.S. Preventive Services Task Force (USPSTF) Guidelines
Client expense: $427,000 · Firm income: —
Matched citations: H.R.2369
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute H.R.2369,VALID Act of 2023
Client expense: $872,000 · Firm income: —
Matched citations: H.R.2369
VALID Act of 2023
2023 · fourth_quarter · Client: BECTON DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
Client expense: $720,000 · Firm income: —
Matched citations: H.R.2369
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
Client expense: $310,000 · Firm income: —
Matched citations: H.R.2369
VALID Act of 2023
2023 · second_quarter · Client: BECTON DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
Client expense: $310,000 · Firm income: —
Matched citations: H.R.2369
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to influenza H.R.2369, VALID Act of 2023
Client expense: $570,000 · Firm income: —
Matched citations: H.R.2369
VALID Act of 2021
2022 · fourth_quarter · Client: BECTON DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021
Client expense: $480,000 · Firm income: —
Matched citations: H.R.4128
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021
Client expense: $480,000 · Firm income: —
Matched citations: S.2209
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
Client expense: $440,000 · Firm income: —
Matched citations: H.R.4128
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
Client expense: $440,000 · Firm income: —
Matched citations: S.2209
VALID Act of 2021
2022 · second_quarter · Client: BECTON DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
Client expense: $500,000 · Firm income: —
Matched citations: H.R.4128
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
Client expense: $500,000 · Firm income: —
Matched citations: S.2209
Triple A Study Act
2022 · first_quarter · Client: BECTON DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Client expense: $650,000 · Firm income: —
Matched citations: H.R.2461
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Client expense: $650,000 · Firm income: —
Matched citations: H.R.2631
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Client expense: $650,000 · Firm income: —
Matched citations: H.R.4128
To amend the Families First Coronavirus Response Act to extend child nutrition waiver authority, and for other purposes.
2022 · first_quarter · Client: BECTON DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Client expense: $650,000 · Firm income: —
Matched citations: S.1089
Data Broker List Act of 2021
2022 · first_quarter · Client: BECTON DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Client expense: $650,000 · Firm income: —
Matched citations: S.2290
VALID Act of 2021
2021 · fourth_quarter · Client: BECTON DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.4760, PASTEUR Act
Client expense: $750,000 · Firm income: —
Matched citations: H.R.4128
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.4760, PASTEUR Act
Client expense: $750,000 · Firm income: —
Matched citations: S.4760
Triple A Study Act
2021 · third_quarter · Client: BECTON DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Client expense: $250,000 · Firm income: —
Matched citations: H.R.2461
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Client expense: $250,000 · Firm income: —
Matched citations: H.R.2631
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Client expense: $250,000 · Firm income: —
Matched citations: H.R.4128
Source: Senate LDA